<DOC>
	<DOCNO>NCT01995175</DOCNO>
	<brief_summary>The purpose study assess incidence associate healthcare utilization RSV-associated , suspect LRTI general population infant birth 2 year age , also assess accuracy newly develop LRTI case definition severity scale compare two exist definition . The study also assess population attributable risk percent RSV LRTI development wheeze asthma 0 6 year age .</brief_summary>
	<brief_title>A Prospective , Epidemiological Study Assess Disease Burden Respiratory Syncytial Virus Associated , Suspected Lower Respiratory Tract Infections Newborns , From 0 2 Years Age Risk Development Wheeze Asthma From 0 6 Years Age</brief_title>
	<detailed_description>New born infant various country world follow two year occurrence Lower Respiratory Tract Infections . Through active passive surveillance , suspect case identify , assessed examination visit follow completion diary card . Full symptomology assess examination visit . The disease course healthcare utilization subsequently collect two-week diary card contact ay healthcare provider involve management disease . RSV detection occur quantitative PCR collect nasal swab . A baseline cord blood serum sample subject follow-up blood serum sample sub-cohort also collect assess antibody level various point time relation risk RSV LRTI . For extension period , pertain wheeze asthma ( Epoch 002 ) : Subjects ' parent ( ) /LAR ( ) ask re-consent subject follow quarterly contact age 6 year . Data collection also occur medical chart retrospectively gap period end primary study provide re-consent extension . The extension involve enrolment visit ( 2nd birthday [ completion primary study soon possible thereafter ] ) quarterly surveillance contact .</detailed_description>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>Before birth : Subject whose parent ( ) /Legally Acceptable Representative ( ) ( LARs ) , opinion investigator , comply requirement protocol . Written informed consent ( include consent obtain cord blood sample birth ) obtain parent ( ) /LAR ( ) subject . After Birth : Subject update resign informed consent confirmation eligibility available later 5 day , birth . New born male female . Blood cord sample collection least 3 ml , birth . For extension period : Subject whose parent ( ) /LAR ( ) , opinion investigator , comply requirement protocol . Written inform consent obtain parent ( ) /LAR ( ) subject . Previous participation primary study ( birth age 2 year ) . Before birth : Subject expect become Child care . Subjects whose parent ( ) /LAR ( ) age 18 legal consenting age respective country high . After Birth : Child care . Newborn gestational age le 28 week . Subjects congenital condition require expect postnatal stay hospital 12 consecutive week . Subjects major congenital defect serious chronic illness limit life expectancy le 5 year . Subjects confirm suspected immunosuppressive immunodeficient condition ( include positive infection human immunodeficiency virus [ HIV ] ) , base medical history , physical examination positive test result . For extension period : â€¢ Child care .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Days</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Respiratory Syncytial virus</keyword>
	<keyword>Cohort study</keyword>
	<keyword>Quarterly phone contact</keyword>
	<keyword>Wheeze</keyword>
	<keyword>New born</keyword>
	<keyword>Lower Respiratory Tract Infection</keyword>
</DOC>